Due to the extensive use of antibacterial agents bacterial resistance to antibiotics has emerged, which has over the years become a serious health threat. Bacterial DNA gyrase and topoisomerase IV are enzymes that regulate the topology of DNA during its replication. Both enzymes have a similar structure, which offers the possiblity of dual-targeting with one antibacterial drug. In this way, the development of bacterial resistance due to target mutations against such an agent slows down.
Siderophores are molecules that bind iron in the environment and transfer it to a bacterial cell. This system of iron uptake can be abused by the Trojan horse strategy in such a way that the bacteria uptake the siderofor-antibacterial agent conjugate. In this way, we can increase the uptake of the active substance into the bacterium.
Our goal was to synthesise new DNA-gyrase inhibitors and their conjugates with siderophore mimetics. The latter were prepared from the kojic acid in several reaction steps, and the benzotiazolpyrrolamide derivatives were used as inhibitors of DNA gyrase B. Chromatographic and spectroscopic methods were used to monitor the course of the reactions and identify the compounds.
In addition to the known DNA-gyrase inhibitor, we also wanted to prepare a novel inhibitor, but the synthesis of 5-hydroxy substituted benzothiazole ring failed. The conjugation of the siderophore mimetic to the known DNA gyrase inhibitor was successful and final compounds 21 and 22 were obtained. The inhibitory activity on recombinant DNA-gyrase and activity against Gram-positive and Gram-negative bacteria were determined, but unfortunately, none of the prepared compounds achieved the desired antibacterial activity. On DNA recombinants, the inhibitory activity in the micromolar range was achieved, but we wanted to achieve a nanomolar range. The cause of low activity is most likely that the siderophores of the final compounds, in comparison with similar previously synthesized compounds having a higher activity, create weaker bonds to the target.
The results of the master's thesis make a significant contribution to the further development of potential antibacterial agents using the Trojan horse strategy, which aims to increase the entry of the inhibitor into the bacterial cell by exploiting the iron transport system.
|